Fusicatenibacter

Information

Microbe Identification

Fusicatenibacter

Microbe id: PMDBM2008965
Level: genus
NCBI Taxonomy ID: 1407607
Taxonomy Species: n.a. [n.a.]
Taxonomy Genus: Fusicatenibacter [1407607]
Taxonomy Family: Lachnospiraceae [186803]

Interactions between microbe and active substances


ⓘ How do we work out MGCs and BGCs of one specific species?


Metabolic gene clusters of Fusicatenibacter

No data available

n.s. indicates that no significant matches were found by KnownClusterBlast.

View gutSMASH Detailed Result
Biosynthetic gene clusters of Fusicatenibacter


No data available

n.s. indicates that no significant matches were found by KnownClusterBlast.

View antiSMASH Detailed Result
Map of Fusicatenibacter distribution in human body and influence of diseases distribution in human body and influence of diseases


ⓘ How do you use the microbe distribution map?
ⓘ How did we get the relative abundance and microbe change in the map?
bodymap Oral Nose Esophagus Stomach Trachea Upper respiratory tract Vagina Blood Urethral Lung Cervix Rectum Skin Duodenum Fallopian tube Fallopian tube Peritoneal fluid Uterus Ear Ovary Ovary Colon Ileum Cecum
Disease id Bodysite Relative abundance (%) Disease name Microbe_change

Relative abundance landscape of Fusicatenibacter in human gut microbiota samples



Abundance lanscape in healthy samples (by patients' age)
Abundance lanscape in healthy samples (by patients' country)
Abundance lanscape in disease samples
⚠ About the relative abundance profile

The relative taxonomical abundance data (pre-processed using a unified analysis pipeline) was retrieved from curatedMetagenomicData resource [Edoardo Pasolli, et al. Nat Methods. 2017;14(11):1023-1024]. Data retrieved here was pre-processed as unified relative abundance: at each taxonomic level (e.g., species, genus, family), the sum of microbial abundance of individual microbiota sample was 1, and relative abundance of each microbe was log10 transformed [relative abundance ranges from -7 to 0].

Healthy samples and disease samples (only disease types with >= 20 samples were included) were grouped by age periods, patients?country, or disease type to plot the relative abundance landscape using ggplot2 R package.



Comparative analysis of human gut metagenomes between disease and healthy samples of Fusicatenibacter

Data source: Phenotype comparisons were obtained from GMrepo . We summarized all comparisons that included healthy samples as controls and overlapped with microbes represented in MASI.

Note: LDA scores below 0 indicate taxa enriched in healthy samples, whereas scores above 0 indicate taxa enriched in disease samples.

Disease Project ID LDA score Experiment Type
Kidney Failure, Chronic PRJEB65297🔗-3.75305824627406mNGS
Kidney Failure, Chronic PRJNA449784🔗3.33219841358212mNGS
Hemangioma, Cavernous PRJNA629755🔗-3.4904683875597mNGS
Hypertension PRJNA509999🔗-3.29106363302448mNGS
Arthritis, Juvenile PRJNA562467🔗-3.9144143920487416S
Diabetes Mellitus, Type 2 PRJNA807457🔗-4.1654818036677116S
Diabetes Mellitus, Type 2 PRJNA661673🔗-3.9554991158982416S
Diarrhea PRJEB14038🔗-4.09542246663238mNGS
Diarrhea PRJNA317326🔗-4.0478754437809316S
Dwarfism PRJNA819198🔗-3.8772490511301916S
Colorectal Neoplasms PRJNA284542🔗-4.4262747252190816S
Colorectal Neoplasms PRJNA698923🔗-4.1439585732604716S
Colorectal Neoplasms PRJNA824020🔗-3.9191292299007716S
Colorectal Neoplasms PRJEB46665🔗-3.8650115285097516S
Colorectal Neoplasms PRJNA1167935🔗-3.84868393030017mNGS
Colorectal Neoplasms PRJDB11845🔗-3.7817599200962816S
Colorectal Neoplasms PRJEB53891🔗-3.71705299864734mNGS
Colorectal Neoplasms PRJNA961076🔗-3.62233820264838mNGS
Colorectal Neoplasms PRJNA731589🔗-3.53328284876373mNGS
Colorectal Neoplasms PRJEB70916🔗-3.52328688640886mNGS
Colorectal Neoplasms PRJNA1138893🔗-3.24747375901179mNGS
Colorectal Neoplasms PRJNA888860🔗-3.16575395933965mNGS
Colorectal Neoplasms PRJNA763023🔗-2.63631447004948mNGS
Gastrointestinal Diseases PRJNA760529🔗-3.7604582707169516S
Tuberculosis PRJNA795263🔗-3.8145957837923316S
Mental Disorders PRJNA278793🔗-3.1594884476095416S
Parkinson Disease PRJEB59350🔗-3.62245045173504mNGS
Colitis, Ulcerative PRJNA804422🔗-4.1830711044695116S
Colitis, Ulcerative PRJNA820056🔗-4.0650227373032716S
Colitis, Ulcerative PRJNA813736🔗-3.90552765483626mNGS
Colitis, Ulcerative PRJNA993675🔗-3.83531463275341mNGS
Colitis, Ulcerative PRJNA983946🔗-3.63168015954621mNGS
Colitis, Ulcerative PRJNA429990🔗-3.22189959075647mNGS
Colitis, Ulcerative PRJNA398089🔗3.13651010035429mNGS
Spinal Cord Injuries PRJNA669472🔗-4.039667939749616S
Spinal Cord Injuries PRJNA861246🔗-3.8572288480203416S
Carcinoma, Hepatocellular PRJNA932948🔗-3.7806418919094mNGS
Carcinoma, Hepatocellular PRJNA872871🔗-3.4314501453453916S
Celiac Disease PRJNA890948🔗-3.6852310902676816S
Narcolepsy PRJEB38491🔗-3.5041702560558316S
Caliciviridae Infections PRJNA788674🔗-4.3040299009156716S
Hepatolenticular Degeneration PRJNA1038771🔗-3.9018715738515616S
Feeding and Eating Disorders PRJEB55035🔗-4.114063386187516S
Psychotic Disorders PRJNA1044118🔗-4.46059864589541mNGS
Lymphoma, Large B-Cell, Diffuse PRJNA906033🔗-3.5267363417707516S
Prostatic Neoplasms PRJNA769284🔗-4.10287837861813mNGS
Prostatic Neoplasms PRJNA762994🔗-3.8461696994892516S
Schizophrenia PRJNA1135717🔗-3.50256263752198mNGS
Hidradenitis Suppurativa PRJEB43835🔗-3.8127370948567616S
Asthma PRJNA950484🔗3.4614288274282316S
Crohn Disease PRJNA820056🔗-4.2308249567886616S
Crohn Disease PRJNA938107🔗-4.167782800814716S
Crohn Disease PRJNA813736🔗-4.05839476286976mNGS
Crohn Disease PRJNA993675🔗-3.83610544658691mNGS
Crohn Disease PRJNA1156939🔗-3.5616616051710116S
Crohn Disease PRJNA429990🔗-3.41398450770358mNGS
Crohn Disease PRJNA793776🔗-3.19854931125338mNGS
Crohn Disease PRJNA398089🔗3.19923083560885mNGS
Cholestasis PRJNA478781🔗-3.4700218636719316S
Meningioma PRJNA626591🔗-3.7521927988462816S
Endometriosis PRJNA715328🔗-3.8672232868951516S
Arthritis, Rheumatoid PRJNA753264🔗-3.8683998220974416S
Arthritis, Rheumatoid PRJNA896336🔗4.03372311359944mNGS
Fatigue Syndrome, Chronic PRJNA751448🔗-3.03050544051306mNGS
Anorexia PRJNA674716🔗-3.69675851535917mNGS
Central Serous Chorioretinopathy PRJEB38997🔗-3.86583352985389mNGS
Cholangiocarcinoma PRJNA932948🔗-3.75873470025233mNGS
Anorexia Nervosa PRJEB38930🔗-3.5504328051133116S
Hepatitis C PRJNA1070593🔗-3.5963945815707116S
Neuroblastoma PRJEB63351🔗-3.7698829609574mNGS
Neuroblastoma PRJNA716780🔗3.84687174923307mNGS
Hematologic Neoplasms PRJNA777832🔗-4.1691668529658316S
Myasthenia Gravis PRJNA688881🔗-3.2745887498847mNGS
Irritable Bowel Syndrome PRJNA637763🔗-4.1033216203066616S
Depressive Disorder, Major PRJNA762199🔗-3.93720644049458mNGS
Depressive Disorder, Major PRJNA591924🔗-3.8580964446242916S
Gastroesophageal Reflux PRJNA993632🔗-4.68539789779951mNGS
Clostridium Infections PRJNA648321🔗-4.20880382682663mNGS
Diabetes, Gestational PRJNA556764🔗3.7592537687870216S
Cholelithiasis PRJNA999028🔗-4.06725527102331mNGS
Liver Cirrhosis PRJNA861246🔗-3.9786267636330616S
HIV Infections PRJDB11949🔗-3.9859569699241116S
HIV Infections PRJNA810567🔗-3.6397286543972216S
HIV Infections PRJNA408085🔗3.0834574249233116S
Autism Spectrum Disorder PRJNA686821🔗-4.19414082955413mNGS
Autism Spectrum Disorder PRJNA917543🔗-3.2562663145608816S
Inflammatory Bowel Diseases PRJNA511372🔗-4.20086715377304mNGS
Inflammatory Bowel Diseases PRJNA993675🔗-3.93839205031487mNGS
Inflammatory Bowel Diseases PRJNA1028828🔗-3.8603015919610116S
Hand, Foot and Mouth Disease PRJNA1017976🔗-4.45735201944416S
Biliary Atresia PRJNA730640🔗-4.52329791288742mNGS
Renal Insufficiency, Chronic PRJNA562327🔗-4.099863679796116S
Renal Insufficiency, Chronic PRJEB65297🔗-3.86183975905469mNGS
Multiple Sclerosis PRJNA875026🔗4.3346377564914916S
Fibromyalgia PRJEB80379🔗-4.38743273273789mNGS
COVID-19 PRJNA678695🔗-4.1334116385256216S
COVID-19 PRJDB13214🔗-4.12490776126364mNGS
COVID-19 PRJNA769052🔗-4.085170123336416S
COVID-19 PRJNA624223🔗-4.06849369510558mNGS
COVID-19 PRJNA689961🔗-3.773795092258mNGS
Sepsis PRJNA641414🔗-3.2385246641514516S

Microbe-Therapeutic Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of therapeutic substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of therapeutic substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Therapeutic substance that metabolized by Fusicatenibacter



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Therapeutic Substances that affect the Fusicatenibacter



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)


Drug involved metabolizing or transporting reactions that are carried out by Fusicatenibacter

No data available!

ⓘ How do we get these drug reactions?

To obtain the reactions associated with therapeutic substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331] database.
Identifying Drug-Associated Reactions: Next, we extracted all reactions that are linked to therapeutic substances from these reconstructions. This involved filtering and identifying reactions specifically related to drug metabolism and transport.
Linking Reaction to Microbes: Utilizing the identified reaction related genes (UidA, Tdc etc.), we machted the corresponding drug-associated reactions to existing microbes in the reconstructions in AGORA2. We could link the presence of these genes in different microbes to the potential for those microbes to carry out the corresponding drug-related reactions.
Putative Drug Reactions: As a result, the drug reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with therapeutic substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGORA2)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGORA2, allowing access to the original .mat files. For more details, visit the AGORA2 repository.

# Model Download
No records found

Detailed Information of drug reactions

Metabolism
Transport
Drug Substrate Drug Metabolite Gene responsible for the reaction Reaction Description Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Substance Name Gene responsible for the reaction Reaction Description Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Herbal Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of herbal substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of herbal substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Traditional medicines/herbs/herbal compounds that metabolized by Fusicatenibacter


Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Traditional medicines/herbs/herbal compounds that affect the Fusicatenibacter



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)

Microbe-Dietary Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of dietary substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of dietary substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGREDA [Ref:Nature Communications, 12 (2021) 4728]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Dietary Substances alter the abundance of Fusicatenibacter

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)





Dietary substance that metabolized by Fusicatenibacter

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)




Dietary Substance involved metabolizing or transporting reactions that are carried out by Fusicatenibacter

ⓘ How do we get these diet reactions?

To obtain the reactions associated with dietary substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGREDA [Ref:Nature Communications, 12 (2021) 4728] database.
Identifying Diet-Associated Reactions: Next, we extracted all reactions that are linked to dietary substances from these reconstructions. This involved filtering and identifying reactions specifically related to dietary substance metabolism and transport.
Linking Reactions to Microbes: Using the identified related genes (e.g., UidA, Tdc) for each drug metabolite reaction, we matched these reactions to microbes possessing the corresponding genes. This allowed us to link the presence of these genes in different microbes to their potential for carrying out the associated drug-related reactions.
Putative Drug Reactions: As a result, the diet reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with dietary substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGREDA)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGREDA, allowing access to the original .xml files. For more details, visit the AGREDA repository.

# Model View
No records found

Detailed Information of diet reactions

Metabolism
Transport
Diet Substrate Enzyme Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Dietary Substance Name Reaction Name Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Environmental Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of environmental substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of environmental substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Environmental Substances that metabolized by Fusicatenibacter



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Environmental Substances that affect the Fusicatenibacter


Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)
ⓘ Background And User Guideline

Microbe Taxonomy level Species Quorum Sensing (QS) Language QS Language Class Total No. of QS Languages of the Species Reference (PubMed ID)


Diseases associated with the microbe Fusicatenibacter


No data available

Microbiota Site Disease Name Disease Association Class Disease Associated Abundence Change Reference (PubMed ID)



Landscape of Bacteria-Substance-Disease Interaction/Association Network



ⓘ How is the network built?